Citation: M. Katai et al., Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: Comparison with sporadic parathyroid adenomas, HORMONE MET, 33(8), 2001, pp. 499-503
Authors:
Nakajima, K
Sakurai, A
Katai, M
Yajima, H
Mori, J
Katakura, M
Tsuchiya, S
Hashizume, K
Citation: K. Nakajima et al., Chromogranin a expression in hepatocellular carcinoma in a patient with germline MEN1 gene mutation, INTERN MED, 39(1), 2000, pp. 20-24
Authors:
Itakura, Y
Sakurai, A
Katai, M
Ikeo, Y
Hashizume, K
Citation: Y. Itakura et al., Enhanced sensitivity to alkylating agent in lymphocytes from patients withmultiple endocrine neoplasia type 1, BIOMED PHAR, 54, 2000, pp. 187S-190S
Authors:
Terai, T
Araho, D
Osakabe, K
Katai, M
Narama, I
Matsuura, T
Katakawa, J
Tetsumi, T
Sato, M
Citation: T. Terai et al., Isolation of iso-grayanotoxin II from leaves of Leucothoe grayana Max. ItsX-ray crystallographic analysis and acute toxicity in mice, CHEM PHARM, 48(1), 2000, pp. 142-144
Authors:
Zhang, X
Danila, DC
Katai, M
Swearingen, B
Klibanski, A
Citation: X. Zhang et al., Expression of prolactin-releasing peptide and its receptor messenger ribonucleic acid in normal human pituitary and pituitary adenomas, J CLIN END, 84(12), 1999, pp. 4652-4655
Authors:
Nakajima, K
Sakurai, A
Kubota, T
Katai, M
Mori, JI
Aizawa, T
Fukushima, Y
Hashizume, K
Citation: K. Nakajima et al., Multiple endocrine neoplasia type 1 concomitant with Prader-Willi syndrome: Case report and genetic diagnosis, AM J MED SC, 317(5), 1999, pp. 346-349